Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endocrine ophthalmopathy].

M Deller

    Klinische Monatsblatter Fur Augenheilkunde
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Graves' disease can cause mild to severe eye problems, including oculomotor issues. Treatment ranges from observation and medication like cortisone to surgery for serious complications.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oestrogen influence on myogenic satellite cells following downhill running in male rats: a preliminary study.

    Acta physiologica Scandinavica·2005
    Same author

    [Prevention of coronary heart disease by therapy of hyperlipidemia. Between cholesterol hysteria and therapeutic realism].

    Fortschritte der Medizin·1992
    Same author

    [Short- and intermediate-term angular results of Cüppers retro-equatorial myopexy, with or without additional simultaneous recession].

    Klinische Monatsblatter fur Augenheilkunde·1991
    Same author

    [Botulinum toxin A in ophthalmology and neurology: our clinical experience over more than 4 years].

    Revue medicale de la Suisse romande·1990
    Same author

    Why should surgery for early-onset strabismus be postponed?

    The British journal of ophthalmology·1988
    Same author

    [Advances in the surgical treatment of isolated oculomotor paralysis].

    Revue medicale de la Suisse romande·1982
    Same journal

    Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    [Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

    Klinische Monatsblatter fur Augenheilkunde·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Endocrinology

    Context:

    • Graves' disease is an autoimmune disorder that can lead to various ocular complications.
    • Ocular manifestations of Graves' disease range in severity and impact.

    Purpose:

    • To outline the spectrum of ocular complications associated with Graves' disease.
    • To discuss management strategies for different severities of Graves' ophthalmopathy.

    Summary:

    • Mild Graves' ophthalmopathy may not require intervention.
    • Moderate to severe cases often necessitate medical treatment with corticosteroids and immunosuppressants.
    • Surgical intervention for extraocular muscle issues is a separate consideration not detailed here.

    Impact:

    • Provides a comprehensive overview of Graves' eye disease for clinicians.
  • Aids in understanding the varied clinical presentations and treatment pathways.
  • Highlights the importance of tailored management based on complication severity.